Published in Gastroenterology on December 01, 2003
Guidelines for the management of inflammatory bowel disease in adults. Gut (2004) 4.15
Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol (2006) 1.73
A nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in Taiwan. BMC Gastroenterol (2013) 1.12
Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) (2010) 1.10
Drug therapy for ulcerative colitis. World J Gastroenterol (2004) 1.07
No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. Clin Gastroenterol Hepatol (2011) 1.05
Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease. Clin Gastroenterol Hepatol (2010) 1.04
Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001. Gut (2004) 0.98
Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflamm Bowel Dis (2013) 0.96
Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut (2006) 0.95
Colorectal cancer in inflammatory bowel disease. Gut Liver (2008) 0.94
Comorbidity in inflammatory bowel disease. World J Gastroenterol (2011) 0.93
Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates. Am J Gastroenterol (2009) 0.91
Is an internal comparison better than using national data when estimating mortality in longitudinal studies? J Epidemiol Community Health (2006) 0.90
Acute and chronic pouchitis--pathogenesis, diagnosis and treatment. Nat Rev Gastroenterol Hepatol (2012) 0.90
Clinical course and prognosis in ulcerative colitis: results from population-based and observational studies. Ann Gastroenterol (2014) 0.88
Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ Health Perspect (2013) 0.88
Alcohol binging causes peliosis hepatis during azathioprine therapy in Crohn's disease. World J Gastroenterol (2007) 0.87
Metabolic syndrome frequency in inflammatory bowel diseases. Saudi J Gastroenterol (2011) 0.84
Inflammatory bowel disease cause-specific mortality: a primer for clinicians. Inflamm Bowel Dis (2014) 0.84
Current trends in inflammatory bowel disease: the natural history. Therap Adv Gastroenterol (2010) 0.84
Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population. J Gastroenterol (2010) 0.83
Clinical epidemiology--how important now? Gut (2005) 0.82
Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.82
Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status. World J Gastroenterol (2014) 0.81
Coagulation parameters in inflammatory bowel disease. Int J Clin Exp Med (2014) 0.81
Infliximab in ulcerative colitis. Biologics (2008) 0.80
Does carotid intima-media thickness increase in patients with inflammatory bowel disease? Intest Res (2014) 0.77
Preventing infective complications in inflammatory bowel disease. World J Gastroenterol (2014) 0.77
Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management. World J Gastroenterol (2014) 0.77
Evaluation of anti-inflammatory effect of anti-platelet agent-clopidogrel in experimentally induced inflammatory bowel disease. Indian J Pharmacol (2012) 0.76
The long-term outcomes of a cohort of Sri Lankan patients with ulcerative colitis: a retrospective study at two national referral centers and review of literature. Clin Exp Gastroenterol (2013) 0.76
Mortality in inflammatory bowel disease: peril and promise. Gastroenterology (2003) 0.75
Prognosis of ulcerative colitis colorectal cancer vs. sporadic colorectal cancer: propensity score matching analysis. BMC Surg (2017) 0.75
Comparing the clinical outcomes of young-onset and adult-onset ulcerative colitis: a multi-center Korean Association for the Study for Intestinal Diseases study. Korean J Intern Med (2016) 0.75
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet (2002) 5.31
Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology (2006) 2.87
Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol (2006) 2.77
Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol (2007) 2.68
Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut (2012) 2.34
Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and follow-up evaluation of malignancy and mortality. Clin Gastroenterol Hepatol (2008) 2.25
Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis (2010) 2.20
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis. Gastroenterology (2013) 2.04
eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Inflamm Bowel Dis (2014) 2.02
Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol (2005) 1.95
The burden of inflammatory bowel disease in Europe. J Crohns Colitis (2013) 1.86
Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis (2006) 1.73
Safety of TNF-α inhibitors during IBD pregnancy: a systematic review. BMC Med (2013) 1.71
Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis (2007) 1.70
Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology (2006) 1.69
Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol (2006) 1.66
Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol (2004) 1.56
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients. J Hepatol (2011) 1.54
Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology (2006) 1.51
FTO gene associated fatness in relation to body fat distribution and metabolic traits throughout a broad range of fatness. PLoS One (2008) 1.49
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology (2006) 1.46
European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis (2010) 1.45
Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology (2002) 1.37
E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut (2010) 1.22
Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm Bowel Dis (2012) 1.22
Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol (2010) 1.21
Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Inflamm Bowel Dis (2002) 1.18
Use of azathioprine and the risk of cancer in inflammatory bowel disease. Am J Epidemiol (2013) 1.18
Fatness-associated FTO gene variant increases mortality independent of fatness--in cohorts of Danish men. PLoS One (2009) 1.14
The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients. Inflamm Bowel Dis (2007) 1.13
Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol (2007) 1.13
Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study. Scand J Gastroenterol Suppl (2006) 1.12
Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol (2013) 1.11
Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota. Am J Gastroenterol (2007) 1.10
Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. Inflamm Bowel Dis (2010) 1.06
Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis (2011) 1.06
Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis (2006) 1.05
Maternal obesity, gestational weight gain, and risk of asthma and atopic disease in offspring: a study within the Danish National Birth Cohort. J Allergy Clin Immunol (2012) 1.05
Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol (2014) 1.04
The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis (2004) 1.01
A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer. BMJ Open (2013) 1.00
Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease course. Scand J Gastroenterol (2007) 1.00
The epidemiology of inflammatory bowel disease. Scand J Gastroenterol (2015) 0.97
Sweet's syndrome--an extraintestinal manifestation in inflammatory bowel disease. Digestion (2005) 0.95
Platelets and anticoagulant capacity in patients with inflammatory bowel disease. Pathophysiol Haemost Thromb (2002) 0.95
Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Syst Rev (2014) 0.95
IBD patients need in health quality of care ECCO consensus. J Crohns Colitis (2008) 0.92
Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease. Am J Gastroenterol (2005) 0.91
Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: A prospective population-based cohort study 2007-2009. Inflamm Bowel Dis (2011) 0.90
Development of a Web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment. Eur J Gastroenterol Hepatol (2010) 0.90
Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel Disease. Inflamm Bowel Dis (2007) 0.89
Alpha-defensin DEFA1A3 gene copy number elevation in Danish Crohn's disease patients. Dig Dis Sci (2011) 0.88
How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)? Clin Chem Lab Med (2005) 0.88
Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J Gastroenterol (2013) 0.88
Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study. J Crohns Colitis (2011) 0.87
Past and current body size affect validity of reported energy intake among middle-aged Danish men. J Nutr (2009) 0.87
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort. Inflamm Bowel Dis (2014) 0.87
NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype-phenotype analysis in Danish and Portuguese patients and controls. Digestion (2005) 0.87
"Best practice" in inflammatory bowel disease: an international survey and audit. Eur J Intern Med (2004) 0.87
Smallpox vaccination and all-cause infectious disease hospitalization: a Danish register-based cohort study. Int J Epidemiol (2011) 0.86
Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Syst Rev (2012) 0.85
Influences of the common FTO rs9939609 variant on inflammatory markers throughout a broad range of body mass index. PLoS One (2011) 0.85
Environmental factors and risk of developing paediatric inflammatory bowel disease -- a population based study 2007-2009. J Crohns Colitis (2012) 0.84
Aetiological factors behind adipose tissue inflammation: an unexplored research area. Public Health Nutr (2012) 0.84
Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study. Inflamm Bowel Dis (2015) 0.84
Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis. Inflamm Bowel Dis (2015) 0.83
Infliximab dependency in a national cohort of children with Crohn's disease. J Pediatr Gastroenterol Nutr (2006) 0.83
Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators--a population-based study. Inflamm Bowel Dis (2010) 0.82
Effect of phenotype on health care costs in Crohn's disease: A European study using the Montreal classification. J Crohns Colitis (2007) 0.82
Efficacy of Infliximab treatment in patients with severe Fistulizing Hidradenitis Suppurativa. J Crohns Colitis (2008) 0.82